Algo version: 0.98b
RGC is listed at the NASDAQ Exchange
RGC [RGC]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is RGC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Regencell Bioscience pays dividends. Last time was Monday 26th of February 2018 where the investors holding the stock on Thursday 15th of February 2018 were paid $0.22000 per share. Over the last 36 times between 2009 and 2018, Regencell Bioscience has paid $7.52 with an average of $0.21 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Regencell Bioscience 10 years ago, but if you had invested on Friday 16th of July 2021 when the price was $10.50, you would have made a loss of $-4.80 per share or -45.71%

Yes, the average daily trading liquidity for Regencell Bioscience is $1.84 million. You should therefore be able to get in and out of your positions relatively fast.

Regencell Bioscience has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Regencell Bioscience to be medium [0.6 out of 1]